Health24.com | Making the most of that fast food meal

It can happen when you’re traveling on business, running late for an appointment, or simply don’t have time to make dinner.

You’re facing fast food or no food.

Quick and easy

Speaking at the Nedbank Franchising Roadshow, Linda Reid, the chief commercial officer at Lightstone Explore, explained that South Africans spend over R2 billion a month on fast food. The amount each household spends depends on household income. According to a study done by Lightstone Explore, South African households, in high income brackets, spend between R1 400 to R1 500 a month on fast food. 

In our fast-paced lives we often don’t really have time to make a proper meal and end up resorting to less-healthy fast food meals. 

Use these tips to make the most of such meals:

Healthier choices

Start by looking for the lowest calorie selections. Some restaurants list the calories and fat content on their menu board. If not, you can do a quick search of its website on your smartphone.

According to US Food and Drug Administration mandates, 2018 is the year that calorie labelling is required for restaurants and similar food establishments that have 20 or more locations. The goal is to make it easy to know what you’re getting in every menu item.

Of course, you don’t necessarily want to choose food by calories alone. Go for lean proteins, like grilled chicken or meat that you can see, not hidden under breading or tucked into a sealed wrap. Have it on a salad rather than a bun, and skip fatty and sugary dressings. Instead, drizzle on oil and vinegar, if available, or use mustard.

If you’re limited to a sandwich, opt for a whole-wheat wrap, or eat only half the bread. Add lettuce, tomatoes and other vegetables, but stay away from toppings like cheese and special sauces.

If there’s no fruit available, fat-free yogurt or frozen yogurt is a healthier sweet ending.

Quick tips

Two caveats:

  • Don’t get trapped into supersized portions or meals that include soda and chips; ask for low-fat milk or water instead.
  • Resist the temptation to order and eat in your car. Walk inside the establishment – you’ll feel more satisfied if you take the time to enjoy your food

Image credit: iStock

NEXT ON HEALTH24X

Share Button

Health24.com | Why am I getting hot flushes?

Researchers report that stimulating particular brain cells triggers hot flushes in mice – a discovery they hope will lead to better therapies for women going through menopause.

Controlling the flushes

Humans also have these brain cells, known as Kiss1 neurons, and the new study suggests they perform similar functions in humans, according to the University of Washington researchers.

And the neurons’ activity is dependent on sex hormones, including oestrogen – which drops in a woman’s body during menopause.

Findings in mice often do not pan out in people, but the researchers noted that a human trial underway in Europe is testing a drug that blocks a protein present in Kiss1 neurons, called NkB.

This latest finding gives added support to that approach, said researcher Christopher Johnson, a neuroscience graduate student at the university.

They might also lead to even more specific treatments, said Stephanie Padilla, a postdoctoral researcher who also worked on the study.

Now, Padilla explained, researchers can continue to look at what happens “downstream” from there, and possibly find targets for drugs that get at the heart of hot flushes.

New options welcome

More refined drugs are needed. Right now, the most common treatment for hot flushes is hormone replacement therapy. But, Johnson pointed out, oestrogen also has widespread effects on the body.

Hormone therapy does effectively ease hot flushes, but new options would be welcome and “practice-changing”, said Dr JoAnn Pinkerton, executive director of the North American Menopause Society.

That’s particularly true, she said, for women who cannot use hormone therapy – including those who’ve had oestrogen-sensitive breast and uterine cancers.

“Relief of hot flashes is an important, unmet need for these women,” Pinkerton said. “Other non-hormone therapies, such as low-dose antidepressants or gabapentin, have not been as effective as hormone therapy.”

For the study, the UW researchers used genetically engineered mice to see what happened when they manipulated Kiss1 neurons. They found that activating the cells triggered a rise in the animals’ skin temperature, followed by an increase in core body temperature.

The effect was most pronounced in female mice whose ovaries were removed to deplete their sex hormone levels.

Additional physiological mechanism

Other research has shown that when oestrogen levels are low, Kiss1 neurons fire at a heightened rate. And that, the researchers suspect, might make women more vulnerable to developing hot flushes in response to some external trigger – such as heat, spicy food or a change in altitude.

According to Padilla, it all raises interesting questions about why these oestrogen-sensitive neurons would be involved in body temperature at all.

One possibility, the researchers speculate, is that during pregnancy, it might be advantageous for women to have an additional physiologic mechanism that helps regulate core body temperature.

The study was published in the journal Cell Reports. 

Image credit: iStock

Share Button

Health24.com | Here’s why dagga can be dangerous if you have a mental disorder

Marijuana, known as dagga in South Africa, has been a controversial plant for a long time. Over the last couple of years, many countries have considered legalising the use of dagga, and South Africa is one of them.

There are strong arguments, both for and against the legalisation of dagga. While it may help some, it has adverse effects on others. We explore why dagga is dangerous if you have a mental disorder.

So what are the effects?

Marijuana is made up of a number of chemicals called cannabinoids. The main ingredients found in cannabinoids are tetrahydrocannabinol (THC) and cannabidiol (CBD). Maja Kwiatkowski, clinical psychologist for Nurture Harmony Recovery and Wellness facility in Hout Bay, describes THC, the chemical responsible for producing the “high”, as a “psychoactive component”.

Professor Wayne Hall, a researcher at the Centre for Youth Substance Abuse Research (CYSAR) at the University of Queensland, said in a study that, “THC may cause anxiety and psychotic behaviours in users.” Kwiatkowski told Health 24, “This is due to various factors such as one’s genetics, medical/psychiatric history, the frequency of use and the amount of marijuana used.” People with mental disorders are therefore at risk of worsening the state of their disorders.

Research shows that cannabis use is linked to depression, bipolar disorder and schizophrenia. The argument linking cannabis to depression is not strong, however. Many studies show that people who suffer from depression use cannabis. Whether cannabis causes depression or depression leads to patients using cannabis to cope with the disorder is unclear.

In a study conducted by the National Drug and Alcohol Research Centre, it was argued that THC affects one’s neurotransmitters and serotonin levels, thus creating depressive symptoms. Using marijuana does put you at risk of damaging your cognitive function. However, it has been found that people with depression often use marijuana as a form of self-medication. THC’s psychoactive components can lead to states of euphoria and relaxation.

Dr Michael West told Health 24 that, “In some studies involving people with bipolar disorder, cannabis use is associated with more frequent periods of illness, and shorter periods of wellness between episodes. The conditions where cannabis appears most harmful are the schizophrenia-spectrum disorders and bipolar disorder. There appears to be a mixed effect on unipolar depression and anxiety with some patients reporting symptom improvement, others symptom worsening and others reporting no effect at all.”

Schizophrenia trigger

Over a 15-year period, a number of Swedish conscripts who had used marijuana by the age of 18, were found to be 2.4 times more likely to be diagnosed with schizophrenia. The study found that had the conscripts avoided using marijuana, 13% of those diagnosed with schizophrenia could have avoided the diagnosis.

But this science is not set in stone. Dr Michael Niss, a psychologist from The Foundation Clinic, based in Johannesburg told Health 24, “The argument for marijuana causing schizophrenia is not convincing… but marijuana has mind-altering capabilities.” THC reacts with the CB1 and CB2 receptors in the body. The CB1 receptor can be found throughout the brain and is thus involved in cognition, motor coordination and memory reward. The CB2 receptor can be found within the immune system and thus explains the pain alleviation effects of THC.

Many experts agree that similar to medication, marijuana has varying effects on people. So while the science is not absolutely clear, it is advisable for people with mental disorders to steer clear of using marijuana. 

Image credit: iStock

NEXT ON HEALTH24X

Share Button

IVF: NHS couples ‘face social rationing’

Eight out of 10 of CCGs in England do not offer IVF to couples if one partner has previous children.

Share Button

Alternative cancer therapies linked to reduced survival

Cancer patients who receive alternative therapies are more likely to shun proven treatments, a study finds.

Share Button

‘Dangerous complacency’ to global HIV epidemic risks resurgence

The response to the global HIV pandemic is risking a resurgence of the disease, experts warn.

Share Button

Rapid cloud clearing phenomenon could provide another piece of climate puzzle

Researchers from North Carolina State University have described rapid and dramatic clearing of low cloud cover off the southwest coast of Africa. This newly observed phenomenon could help climatologists understand how clouds affect Earth’s heating and cooling.

While reviewing many years of satellite data from NASA and the European Organisation for the Exploitation of Meteorological Satellites (EUMETSAT), NC State atmospheric scientist Sandra Yuter and her team noticed abrupt clearings of cloud cover off the coasts of Namibia and Angola.

“Large areas of low cloud are a normal feature over the ocean in the subtropics west of continents,” Yuter says. “What is unusual in this case is that the cloud erosion occurs rapidly along an organized line hundreds of miles long, like a sun shade being pulled away. The lines can move west for a day or more and clear out a cloud area more than twice that of California.”

The rapid cloud removal events happen throughout the year and peak in May — occurring on over half the days of the month. Yuter and her team noted that the wind direction at cloud level was often perpendicular to that of the clearing. This shows the cloud is not pushed away by the wind. The clearings start off the coast around midnight and continue through the night and the following day, suggesting that solar heating does not cause these events. “This kind of cloud erosion has never been documented before,” Yuter says. “How it happens is still a mystery, although we theorize that atmospheric gravity waves are the most likely mechanism.

“These waves cause up-and-down motions in the atmosphere, akin to a boat bobbing on the ocean. We hypothesize that offshore winds from Africa interact with stable air over the ocean to make these waves, which then move through the cloud field and promote mixing and cloud evaporation.”

Yuter believes that this discovery will improve scientists’ understanding of climate processes. “We were very surprised by what we found,” she says. “This is a way of changing large cloud areas that has not been documented before. Scientists are interested in anything that changes the area of low clouds over the ocean because these clouds reflect sunlight and cool the Earth.

“Understanding how this happens will help us predict what might happen to clouds in a warming climate,” Yuter adds. “It’s about the balance of warming and cooling effects — and this is one of the pieces that make up that balance.”

Video: https://www.youtube.com/watch?v=Rh-iPQraOnk

Story Source:

Materials provided by North Carolina State University. Note: Content may be edited for style and length.

Share Button

Mixed mRNA tails act like a shield that delays its shortening

One method cells have to reliably curb the amount of specific proteins at any desired time is the control on mRNA degradation. As the mRNA’s tail plays a role in this process, biologists at the Center for RNA Research, within the Institute for Basic Science (IBS, South Korea), have identified how mixed tails — made of different nucleotides — protect mRNA from degradation for longer. Published in Science, these findings could bring new insights to our understanding of gene regulation in healthy and diseased states.

mRNA is a delicate molecule with an important function; it brings genetic information contained in the DNA out of the nucleus to produce proteins. When a gene is transcribed into messenger RNA (mRNA), the mRNA is equipped with a tail, that acts like a shield against pre-mature degradation.

Until recently, mRNA tails were thought to be merely a chain of hundreds of adenosine (A) monophosphate nucleotides, and was thus commonly called the poly(A) tail. Specific enzymes lengthen and shorten the tail by adding and pruning A’s from its end: poly(A) polymerases add a chain of around 200 A’s; and deadenylases, such as the CNOT complex, trim down the poly(A) tails over time starting from the A’s at the tip of the tail.

In 2014, IBS researchers discovered that the mRNA tail is not limited to A’s. They developed a high-throughput sequencing method, TAIL-seq, to accurately measure the length of poly(A) tails at a genome-wide scale. They found out that other nucleotides other than A’s, like guanosine (G), uridine (U) and cytosine (C), decorated the tail end. Mixed tails were reported in an evolutionarily broad range of species, including: humans, mice, frogs, and fish, adding further importance to this topic.

In this current study, IBS researchers found out that some of the enzymes that insert A’s to the tail, are able to add also G’s, U’s, and C’s, creating a mixed tail. In particular, nucleotidyltransferase TENT4A/B intermittently adds G’s when extending the mRNA tail. Interestingly, in cells G’s are located mainly at the very end of the tail, or at the next to last position. This can be explained by the fact that the enzymes that prune the poly(A) tails stall when they encounter a G, rather than an A, at the end of the tail. In other words, the research team found out that a G addition may slow down the trimming of the tail, thereby protecting it.

“Non-adenosines added by TENT4A/B have a considerable stalling effect. Just one is enough to counteract poly(A) trimming enzymes and stabilize the mRNA,” explains Young-suk Lee, one of the authors of the study. The mRNAs with mixed tails were indeed reduced in cells lacking TENT4A/B.

“The mRNA tail has been considered a pure stretch of A’s with little informational content, except for its length. However, this study proves that even tails of the same length can have different composition, and a mixed tail degrades more slowly than the pure poly(A) tail,” explains KIM Narry, corresponding author of the study and director of the Center. “Through this study, we can understand the life history of complex mRNA by revealing a new kind of mRNA protection mechanism that was not known before.”

In the future, the team would like to expand their research to various biological systems, and to understand how misbehaving tailing mechanisms can lead to various diseases. In addition, they would like to develop a RNA-based gene therapy method that utilizes the mixed tailing effect in cells to enhance mRNA stability.

Story Source:

Materials provided by Institute for Basic Science. Note: Content may be edited for style and length.

Share Button

Discovery of kidney cancer driver could lead to new treatment strategy

University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change can lead to an overabundance of blood vessels, which help feed nutrients to the tumors. Their latest finding shows a potential new cancer-driving pathway.

More than 90 percent of the most common type of kidney cancer have a genetic change that leads to the loss of an important tumor suppressor gene called VHL. In a study published in the journal Science, researchers identified a new downstream effect of this genetic change that is helping to drive kidney cancer: They found that a protein called ZHX2 over-accumulates in these cells and helps to turn on other signals involved in cancerous growth. Their findings suggest that ZHX2 is a potential new therapeutic target for clear cell renal cell carcinoma, which is the most common type of kidney cancer.

“If you lose VHL, you will accumulate lots of this ZHX2 protein, which will turn on signals that promote kidney cancer,” said UNC Lineberger’s Qing Zhang, PhD, an assistant professor in the UNC School of Medicine Department of Pathology & Laboratory Medicine and Pharmacology. “This protein could be a potential therapeutic target used to treat kidney cancer on its own or in combination. The next step is to try to figure out how we can target it therapeutically.”

Renal cell clear cell carcinoma is the most common type of kidney cancer, accounting for about 70 percent of all cases, researchers report. Approximately 90 percent of patients with clear cell renal cell carcinoma have genetic mutations or alterations that cause them to lose the function of VHL. When the function of VHL is gone, cells can accumulate signals that trigger blood vessels to grow.

“VHL is the most important tumor suppressor in clear cell renal cell carcinoma,” Zhang said. “There are extensive reports showing that from initiation to tumor progression to metastasis — during the whole process of kidney cancer development — VHL plays a central role. It is important to understand how the VHL loss contributes to kidney cancer, and how we can therapeutically target the downstream effects of this loss in kidney cancer.”

There are U.S. Food and Drug Administration-approved drugs that block cell signals involved in abnormal blood vessel production — which is a downstream effect of VHL loss — that are part of the standard of care for clear cell renal cell carcinoma. Patients can show little response to these drugs or can develop resistance, so Zhang and his colleagues wanted to search for other targets that accumulate in cells lacking VHL function that help to drive the abnormal cancerous growth.

“We wanted to understand, once VHL is lost, what else in kidney cancer cells is promoting oncogenesis?” Zhang said. “Therapeutically speaking, we’re trying to understand how we can target these novel signaling pathways, once we identify them.”

The researchers created a screening technique to discover new molecules that might help drive cancer when VHL is lost. This led them to determine that kidney cancer cells lacking VHL usually had more ZHX2. By eliminating ZHX2 from their laboratory models, they inhibited cancer cell growth, invasion and the cancer’s spread. In addition, they saw that it was involved with signals that can help cancer cells grow.

UNC Lineberger’s William Kim, MD, said there have been major advances in the treatment of kidney cancer with the development of molecularly-targeted therapies and immune-based treatments. However, additional treatments are needed to reach more patients with metastatic disease.

“The vast majority of kidney cancers have mutations in VHL, so it makes it a very important gene to investigate,” said Kim, who is an associate professor of medicine and genetics in the UNC School of Medicine. “In the last decade or more, we’ve had quite a number of major treatment advances in kidney cancer. There are nearly a dozen FDA-approved treatments now for this disease, but many of them are similar. Studies like this are important because they delineate the underlying biology of kidney cancer and identify novel, distinct pathways to develop drugs against.”

In addition to Zhang and Kim, the other authors are Jing Zhang, Tao Wu, Jeremy Simon, Mamoru Takada, Ryoichi Saito, Cheng Fan, Xian-De Liu, Eric Jonasch, Ling Xie, Xian Chen, Xiaosai Yao, Bin Tean Teh, Patrick Tan, Xingnan Zheng, Mingjie Li, Cortney Lawrence, Jie Fan, Jiang Geng, Xijuan Liu, Lianxin Hu, Jun Wang, Chengheng Liao, Kai Hong, Giada Zurlo, Joel S. Parker, J. Todd Auman, Charles M. Perou, W. Kimryn Rathmell, Marc W. Kirschner, William G. Kaelin Jr., and Albert S. Baldwin.

The study was supported by a U.S. Department of Defense Career Development Award, the University Cancer Research Fund, and the National Cancer Institute. Individual researchers were supported by the V Foundation for Cancer Research, Kimmel Scholar award, Susan G. Komen, the Mary Kay Foundation, the U.S. Department of Defense, the Howard Hughes Medical Institute, the NCI, the National Medical Research Council, and the Biomedical Research Council.

Share Button

Plan to teach all children first aid

It comes after an inquiry into the Manchester bombing found that many adults lacked life-saving skills.

Share Button